This invention is directed to Amino substituted Aryloxybenzylpiperidine derivatives which are ligands at the MCH1 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/ or anxiety which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention.
申请公布号
WO2006041636(A3)
申请公布日期
2006.06.15
申请号
WO2005US33891
申请日期
2005.09.20
申请人
H.LUNDBECK A/S;MARZABADI, MOHAMMAD, R.;CHEN, CHIEN-AN;YU, JIANG;LU, KAI;ANDERSEN, KIM
发明人
MARZABADI, MOHAMMAD, R.;CHEN, CHIEN-AN;YU, JIANG;LU, KAI;ANDERSEN, KIM